| Host: |
Rabbit |
| Applications: |
WB/ELISA |
| Reactivity: |
Human |
| Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Clonality: |
Monoclonal |
| Clone ID: |
SRM |
| Conjugation: |
Unconjugated |
| Isotype: |
IgG |
| Formulation: |
PBS with 0.09% Sodium Azide, 0.05% BSA, 50% Glycerol, pH 7.3. |
| Purification: |
Affinity purification |
| Concentration: |
Lot specific |
| Dilution Range: |
WB:1:24000-1:144000ELISA:Recommended starting concentration is 1 Mu g/mL. Please optimize the concentration based on your specific assay requirements. |
| Gene Symbol: |
CTAG1A.CTAG1B |
| Gene ID: |
1485/246100 |
| Uniprot ID: |
CTG1B_HUMAN |
| Immunogen Region: |
1-100 aa |
| Specificity: |
A synthetic peptide corresponding to a sequence within amino acids 1-100 of human NY-ESO-1 0. |
| Immunogen Sequence: |
MQAEGRGTGGSTGDADGPGG PGIPDGPGGNAGGPGEAGAT GGRGPRGAGAARASGPGGGA PRGPHGGAASGLNGCCRCGA RGPESRLLEFYLAMPFATPM |
| Tissue Specificity | Expressed in testis and ovary and in a wide variety of cancers. Detected in uterine myometrium. Expressed from 18 weeks until birth in human fetal testis. In the adult testis, is strongly expressed in spermatogonia and in primary spermatocytes, but not in post-meiotic cells or in testicular somatic cells (at protein level). |
| Protein Name | Cancer/Testis Antigen 1Autoimmunogenic Cancer/Testis Antigen Ny-Eso-1Cancer/Testis Antigen 6.1Ct6.1L Antigen Family Member 2Lage-2 |
| Cellular Localisation | Cytoplasm |
| Alternative Antibody Names | Anti-Cancer/Testis Antigen 1 antibodyAnti-Autoimmunogenic Cancer/Testis Antigen Ny-Eso-1 antibodyAnti-Cancer/Testis Antigen 6.1 antibodyAnti-Ct6.1 antibodyAnti-L Antigen Family Member 2 antibodyAnti-Lage-2 antibodyAnti-CTAG1A antibodyAnti-CTAG antibodyAnti-CTAG1 antibodyAnti-ESO1 antibodyAnti-LAGE2 antibodyAnti-LAGE2A.CTAG1B antibodyAnti-LAGE2B antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance
